Public Profile

Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.

Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd., commonly referred to as Xiuzheng Pharmaceutical, is a prominent player in the pharmaceutical industry, headquartered in Jilin City, China. Established in 1998, the company has made significant strides in the development and production of traditional Chinese medicine and modern pharmaceuticals, catering to both domestic and international markets. With a diverse portfolio that includes herbal medicines, chemical drugs, and health supplements, Xiuzheng Pharmaceutical stands out for its commitment to quality and innovation. The company has achieved notable milestones, including various certifications and recognitions that underscore its market position. As a leader in the pharmaceutical sector, Xiuzheng continues to expand its operational footprint, contributing to advancements in healthcare and wellness solutions.

DitchCarbon Score

How does Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.'s score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

44%

Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.'s reported carbon emissions

Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd., headquartered in China, currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is unclear how the company is addressing climate change or its carbon footprint. As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Jilin Xiuzheng to establish clear climate commitments and reduction initiatives to align with global efforts in combating climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd. is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Jilin Xiuzheng Pharmaceutical Group Stock Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Baiyunshan

CN
Chemical and fertilizer minerals, salt and other mining and quarrying products n.e.c.
Updated 5 days ago

Bayer

DE
Chemicals nec
Updated 5 days ago

Cr Pharmaceutical

HK
Medical, precision and optical instruments, watches and clocks (33)
Updated about 12 hours ago

Kelun Group

CN
Chemicals nec
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers